Iv Infusion Articles & Analysis: Older
4 articles found
Background A 16 y/o male with a history of irritable bowel disease presents to the Emergency Department vomiting blood. He has an ostomy in place. His initial vital signs were BP 82/59, HR 160, SI 1.95. He was ill-appearing, with skin gray and ashen. The staff placed a 20-gauge peripheral IV and infused a 1-liter NS bolus using the LifeFlow PLUS and the QinFlow Warrior blood and fluid warmer. ...
Citation: Huddleston M, Estep J, “Drug Delivery: What do Patients and Providers Want?” ONdrugDelivery, Issue 124 (Sep 2021), pp 10–14. Matthew Huddleston and Jennifer Estep discuss current drug delivery options and the value of convenient care. Worldwide, patient and provider preferences are changing due to the covid-19 pandemic. The need to reduce patient exposure to the ...
IMPORTANT MESSAGE: Benzinga prides itself as a media platform that is "For the People, By the People." We understand the markets are scary right now. For that reason, we are here to help. For today only get access to our #1 Options Newsletter for only $1. Rani Therapeutics Holdings, Inc. RANI+ Free Alerts, a San Jose, California-based early stage biopharma, debuted Friday on the Nasdaq ...
After a lightning round of proposals and reviews, an international team of scientists led by Dr. Camillo Ricordi was granted immediate FDA authorization for a 24-patient clinical trial to test the safety and exploratory efficacy of umbilical cord-derived mesenchymal stem cells (UC-MSCs) to block the life-threatening lung inflammation that accompanies severe cases of COVID-19. The therapy uses ...